A study of methotrexate in patients with psoriasis found that the immunosuppressive drug was more effective in patients without psoriatic arthritis than those with the added condition.
Scaling up prevention, treatment, and screening interventions can make substantial strides toward global hepatitis C elimination.
Top news of the day across the health care landscape.
Top news of the week from Specialty Pharmacy Times.
The FDA has approved sumatriptan nasal spray (Tosymra) for the acute treatment of migraine with or without aura in adults.
The approval is based on data demonstrating improved progression-free survival and overall survival in patients with metastatic nonsquamous non-small cell lung cancer.
Most state pharmacy regulations do not specifically require verification of the prescriber’s license prior to dispensing.

Most Popular

Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.